After underperforming the overall market for the past few years, large-cap pharmaceutical stocks may now be positioned to ...

UPS declined to comment. FedEx did not directly address the issue. Pharmaceutical products have long been spared from trade ...

Trump imposed a 10% tariff on most U.S. imports, as well as much higher levies on dozens of rivals and allies alike, but ...

Use precise geolocation data. Actively scan device characteristics for identification. Store and/or access information on a ...

Drugmakers are lobbying Trump to phase in tariffs on imported pharmaceutical products in hopes of reducing the sting from the ...

Leerink Partners analyst David Resinger warned his clients on Sunday that the tariff risks to the industry are ...

Pharma’s reprieve from Donald Trump’s tariffs is expected to be temporary, with Leerink analysts anticipating possible sector ...

TempPack sessions at ISTA Forum highlight the need for effective shipping to transport the growing demand for ...

The talks between the administration and the industry, which have been taking place behind closed doors, have given some ...

CLSA said that even if tariffs are imposed, Indian drug makers are likely to pass on the costs, given their dominant market ...

GROUPE LSL PHARMA INC (TSXV: LSL) (TSXV: LSL.DB) (the "Company" or "LSL Pharma"), a Canadian integrated pharmaceutical ...